Natco Pharma’s marketing partner BPI obtains FDA approval for new drug

By Nikita Chaurasia  | Date: 2021-03-10

Natco Pharma’s marketing partner BPI obtains FDA approval for new drug

Breckenridge Pharmaceutical Inc. (BPI), a marketing partner of Natco Pharma, has reportedly received U.S. Food and Drug Administration (USFDA) approval for its Abbreviated New Drug Application of Everolimus drug tablets.

The drug is basically a generic version of Afinitor and is primarily used for breast cancer treatment, as well as for treating other types of cancer. Sources confirmed that BPI is planning to launch tablets of 7.5 mg, 5 mg, and 2.5 mg strengths in the upcoming weeks.

The company will reportedly launch its 10 mg strength drugs after a licensing agreement and settlement with the owner of the Afinitor brand. A representative from Natco Pharma commented that the launch will be announced at a later date.

For those unaware, Breckenridge Pharmaceutical Inc. is a subsidiary of Japan-based Towa Pharmaceutical Co. Ltd. The company is headquartered in Berlin, Connecticut, and manufactures, distributes as well as markets over 82 pharmaceutical drugs in the U.S.

It has more than 40 Abbreviated New Drug Applications (ANDA) approved by the Food and Drug Administration and manufactures drugs in several categories including capsules, tablets, liquids, ophthalmics, transdermal patches, powders, nasal sprays, and injectable products.

BPI has partnered with manufacturers from across the world and aims to provide generic pharmaceuticals that are affordable and cost-effective to U.S. patients.

Recently, another Hyderabad-based drug maker, MSN Group, which also has a marketing partnership with BPI, announced that it had received final approval from USDA for its ANDA for Asenapine Sublingual Tablets.

MSN had earlier received final approval for 10 mg and 2.5 mg strengths of the same drug. The product will be launched by its marketing partner Breckenridge Pharmaceutical. The approved product is a generic version of Saphris and is employed for the treatment of bipolar disorder and schizophrenia.

According to MSN, Asenapine had recorded annual sales of USD 239 million during the year ending in September 2020.

Source Credits –

https://www.thehindu.com/business/natco-pharma-marketing-partner-bpi-gets-usfda-nod-for-anti-cancer-drug/article34022425.ece

 

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Zomato net loss triples to USD 46 million despite 75% jump in revenues

Zomato net loss triples to USD 46 million despite 75% jump in revenues

By Nikita Chaurasia

Indian food delivery giant Zomato Limited has reported a net loss worth USD 46 million in Q4 of FY2021-22 despite witnessing a 75% growth in revenue to USD 156 million as opposed to USD 89 million it earlier recorded during the fourth quarter of the ...

Facebook-owner Meta to share more data on political advertisements

Facebook-owner Meta to share more data on political advertisements

By Nikita Chaurasia

Facebook-parent Meta Platforms Inc has recently announced that it would provide additional data from its public ad database regarding the targeting decisions made by publishers running social and political-issue advertising. As a part of the expan...

Massachusetts finds first 2022 monkeypox case in the United States

Massachusetts finds first 2022 monkeypox case in the United States

By Nikita Chaurasia

The Massachusetts Department of Public Health has recently reported the first case of a rare infection called monkeypox in a man who recently visited Canada. According to Boston’s public department, the identified case is no threat to the pu...

Russia denies plans of blocking YouTube & cutting off from the internet

Russia denies plans of blocking YouTube & cutting off from the internet

By Nikita Chaurasia

The Digital Development Minister of Russia has reportedly stated that the country is not planning to block Google’s video streaming platform YouTube as such a move would affect its users and will therefore be avoided.  It is worth notin...

Indian food delivery giant Swiggy to buy Dineout from Times Internet

Indian food delivery giant Swiggy to buy Dineout from Times Internet

By Nikita Chaurasia

Swiggy, an Indian food delivery giant, has recently announced an agreement with Times Internet to buy Dineout, a dining and restaurant technology platform. Swiggy will use the acquisition to enter the dining out (non-delivery) market, where it will c...